PER 0.00% 8.1¢ percheron therapeutics limited

News: ANP Antisense Therapeutics says ATL1102 for MS Phase IIb IND submitted to FDA for review, page-20

  1. 3,122 Posts.
    lightbulb Created with Sketch. 621
    No, I will still question it & the extraordinary size of his salary.
    I do now see a glimmer of light at the end of the tunnel though
    Last edited by Logzy: 27/06/17
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢
Change
0.000(0.00%)
Mkt cap ! $83.97M
Open High Low Value Volume
8.0¢ 8.1¢ 8.0¢ $61.91K 766.3K

Buyers (Bids)

No. Vol. Price($)
4 549730 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.1¢ 94626 1
View Market Depth
Last trade - 15.59pm 31/10/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.